About Sientra

Headquartered in Irvine, California, Sientra is a medical aesthetics company focused on empowering people to change their lives through increased self-confidence and self-respect. Backed by unrivaled clinical and safety data, Sientra’s platform of products includes a comprehensive portfolio of round and shaped breast implants, the first fifth-generation breast implants approved by the FDA for sale in the United States, the ground-breaking AlloX2 breast tissue expander with patented dual-port and integral drain technology, the next-generation AlloX2Pro™, the first and only FDA-cleared MRI-compatible tissue expander, the Viality™ with AuraClens™ enhanced viability fat transfer system, the SimpliDerm Human Acellular Dermal Matrix, and BIOCORNEUM the #1 performing, preferred and recommended scar gel of plastic surgeons (data on file).

To learn more, follow Sientra on LinkedIn, Instagram and Facebook.


Nasdaq: SIEN

Stock Quote: NASD

$0.17 -0.04
Volume 3,435,111
Previous Close 0.21
Intraday High 0.20
Intraday Low 0.16
Pricing delayed 20 minutes
Price Change % Change -18.69% 52 Week High 4.94 52 Week Low 0.16 Today's Open 0.19 Feb 21, 2024 04:00 PM

Investor Contact

Sientra Investor Relations